Clinical research group Icon has lowered its revenue forecast for 2008 due to currency movements.
It said it expected to report revenue of between $862m and $865m this year. But Icon signalled that its earnings per share would be higher than previously forecast at $1.27 to $1.29.
For 2009, Icon projected revenues of $930m to $980m and earnings per share of $1.40 to $1.52.
The Dublin-based company provides outsourced services to the pharmaceutical, biotechnology and medical device industries.
